Annals of Neurology

Article	Citations
Annals of Neurology: Volume 90, Number S27, October 2021	172
Association of Retromer Deficiency and Tau Pathology in Down Syndrome	163
Cerebrospinal Fluid Flow in Patients with Huntington's Disease	140
Supratentorial Lymphocytic Inflammation with Parenchymal Perivascular Enhancement Responsive to Steroids: A Potentially Overlooked Diagnosis	127
A Managed Care System with Telemedicine Support for Neurological Emergencies	117
Dysregulation of Gut Microbiota‐Derived Neuromodulatory Amino Acid Metabolism in Human Immunodeficiency Virus‐Associated Neurocognitive Disorder: An Integrative Metagenomic and Metabolomic	113
Issue Information	108
Hypoparathyroidism Associated with Vascular Centrum Semiovale Calcifications	100
A Letter Concerning a Role for Blood–Brain Barrier Dysfunction in Delirium following Noncardiac Surgery in Older Adults	97
Furthering Female Faculty: An American Neurological Association/Association of University Professors of Neurology Perspective	94
Blood Pressure after Successful Endovascular Therapy: A Systematic Review and Meta‐Analysis of Randomized Control Trials	93
Interactions between High Seroreactivity to Human Herpes Virus 6A and Epstein–Barr Virus in MS Development: A Presymptomatic Case–Control Study	92
Cortical Microhemorrhage Presentation of Small Vessel Primary Angiitis of the Central Nervous System	91
Elevated Cerebrospinal Fluid Ubiquitin Carboxyl‐Terminal Hydrolase Isozyme L1 in Asymptomatic C9orf72 Hexanucleotide Repeat Expansion Carriers	88
The Use of Antihypertensive Medication and In Vivo Alzheimer's Disease Pathology	88
HLA Associations of Intrathecal IgG Production against Specific Viruses in Multiple Sclerosis	88
Issue Information	83
Human Brain Resilience: A Call to Action	83
Before, during, and after: An Argument for Safety and Improved Outcome of Thrombolysis in Acute Ischemic Stroke with Direct Oral Anticoagulant Treatment	76
Carotid Stent Fracture	75
Annals of Neurology: Volume 97, Number 1, January 2025	75
	74
Efficacy and Safety of Ofatumumab Treatment for Anti‐NMDA Receptor Autoimmune Encephalitis (OFF‐AE): A Prospective, Multicenter Cohort Study	70
	69
Biological Age Acceleration and Motoric Cognitive Risk Syndrome	67

Speech Biomarkers in Rapid Eye Movement Sleep Behavior Disorder and Parkinson Disease	67
Guanylate Kinase 1 Deficiency: A Novel and Potentially Treatable Mitochondrial DNA Depletion/Deletions Disease	67
Polygenic Risk Score for Alzheimer's Disease in Caribbean Hispanics	63
Diet, Pace of Biological Aging, and Risk of Dementia in the Framingham Heart Study	63
Network Localization of Awareness in Visual and Motor Anosognosia	62
Septin‐5 and ‐7‐IgGs: Neurologic, Serologic, and Pathophysiologic Characteristics	60
Management of Cerebral Venous Thrombosis Due to Adenoviral COVID‐19 Vaccination	58
Vertebral Artery Pseudoaneurysm: Novel Marker of Bow Hunter's Syndrome	58
Effect of Imaging Markers on Reperfusion Therapy in Basilar Artery Occlusion	57
Staufen Impairs Autophagy in Neurodegeneration	55
MS‐Driven Metabolic Alterations Are Recapitulated in iPSC‐Derived Astrocytes	55
Epidemiology, Survival, and Clinical Characteristics of Inclusion Body Myositis	53
Suvorexant Acutely Decreases Tau Phosphorylation and Aβ in the Human CNS	52
Plasma Metabolites Link Dietary Patterns to Stroke Risk	50
Severity of GNAO1‐Related Disorder Correlates with Changes in G‐Protein Function	49
A Role for Insulin‐like Growth Factor 1 in the Generation of Epileptic Spasms in a murine model	48
Probabilistic Mapping Reveals Optimal Stimulation Site in Essential Tremor	48
Sports Concussion and Category Mistakes	47
Annals of Neurology: Volume 94, Number S30, September 2023	46
Annals of Neurology: Volume 90, Number S26, September 2021	45
Reply to “Core Penumbral Mismatch: An Independent Predictor of Stroke Poorer Outcome”	45
Cover Image	44
Improving Early Recognition of Treatment‐Responsive Causes of Rapidly Progressive Dementia: The STAM3P Score	44
Issue Information	43
GABRA1‐Related Disorders: From Genetic to Functional Pathways	43
A Combined Panel of Salivary Biomarkers in de novo Parkinson's Disease	43
GGC Repeat Expansion of RILPL1 is Associated with Oculopharyngodistal Myopathy	43
Micro‐Doses of DNP Preserve Motor and Muscle Function with a Period of Functional Recovery in Amyotrophic Lateral Sclerosis Mice	42
Illusions of Self‐Motion during Magnetic Resonance‐Guided Focused Ultrasound Thalamotomy for Tremor	42
Association of Seizure Control with Mortality, Cognition, and Function in People With Dementia	42
APOE2 Exacerbates TDP‐43 Related Toxicity in the Absence of Alzheimer Pathology	42
Subicular Caspase‐1 Contributes to Pharmacoresistance in Temporal Lobe Epilepsy	42
Intravenous Thrombolysis in Patients Taking Direct Oral Anticoagulation Treatment Before Stroke Onset: Results from the Safe Implementations of Treatments in Stroke International Stroke Registry	40
ANA Investigates: Tenecteplase	40
RAN Translation of C9orf72‐Related Dipeptide Repeat Proteins in Zebrafish Recapitulates Hallmarks of Amyotrophic Lateral Sclerosis and Identifies Hypothermia as a Therapeutic Strategy	39
Tenascin‐R Autoimmunity: Isolated Tremor Reversed with Immunotherapy	39
Correction: GATA1‐Mediated Transcriptional Regulation of the γ‐Secretase Activating Protein Increases Aβ Formation in Down Syndrome	39
MEK Pathway Inhibitor‐Mediated Response in BRAF V600‐Mutant Melanoma with Brain Parenchymal and Leptomeningeal Metastases	39
Correction: Regional Glymphatic Abnormality in Behavioral Variant Frontotemporal Dementia	39
Regional Brain Metabolism across the Alzheimer's Disease Continuum in Down Syndrome	38
Development of Parkinson Disease and Its Relationship with Incidentally Discovered White Matter Disease and Covert Brain Infarction in a Real‐World Cohort	38
Dopamine Transporter Imaging as Objective Monitoring Biomarker in Parkinson's Disease	38
Preservation of Brain Activity in Unresponsive Patients Identifies MCS Star	37
Choroid Plexus Enlargement Exacerbates White Matter Hyperintensity Growth through Glymphatic Impairment	36
Trials for Slowly Progressive Neurogenetic Diseases Need Surrogate Endpoints	36
Longitudinal Imaging Biomarkers Correlate with Progressive Motor Deficit in the Mouse Model of Charlevoix‐Saguenay Ataxia	36
Issue Information	35
Annals of Neurology: Volume 90, Number 3, September 2021	35
Neuroimaging Biomarkers for Friedreich Ataxia: A Cross‐Sectional Analysis of the TRACK‐FA Study	35
Ultrastructural Axon–Myelin Unit Alterations in Multiple Sclerosis Correlate with Inflammation	35

Bleeding Risk of Dual Antiplatelet Therapy after Minor Stroke or Transient Ischemic Attack	34
Compensated Hypogonadism Identified in Males with Cluster Headache: A Prospective Case‐Controlled Study	34
Foslevodopa/Foscarbidopa: A New Subcutaneous Treatment for Parkinson's Disease	34
	34
Reply to “Clinical Relevance of Genetic Variants in Juvenile Stroke Patients: A Plea for a Precise Classification”	34
Typical Radiological Features of a Rare Lateral Ventricular Liponeurocytoma	34
Genome‐Wide Analysis of Structural Variants in Parkinson Disease	33
Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy Is Associated with HLA‐A*3303 and HLA‐DPB1*0501	33
Seizures after Ischemic Stroke: A Matched Multicenter Study	33
Stage‐Dependent Biomarker Changes in Spinocerebellar Ataxia Type 3	33
Brain Iron Dysregulation in Iron Deficiency Anemia‐Related Restless Leg Syndrome Revealed by Neuron‐Derived Extracellular Vesicles: A Case–Control Study	33
Signs of Cortical Inflammation in Migraine Measured with Quantitative Magnetic Resonance Imaging: A Registry for Migraine (REFORM) Study	32
Greater Diffusion Restriction in White Matter in Preclinical Alzheimer Disease	32
NINDS Corner: The Helping to End Addiction Long‐Term Initiative and Pain Neurology	32
Responsiveness of the Scale for the Assessment and Rating of Ataxia and Natural History in 884 Recessive and Early Onset Ataxia Patients	32
Automated Neuroprognostication Via Machine Learning in Neonates with Hypoxic‐Ischemic Encephalopathy	31
Bilateral Hearing Loss Caused by Inferior Collicular Infarction	31
COVID‐19‐Associated Critical Illness Myopathy with Direct Viral Effects	31
Fighting Amyotrophic Lateral Sclerosis by Protecting the Liver? A Prospective Cohort Study	31
Actigraphy Enables Home Screening of Rapid Eye Movement Behavior Disorder in Parkinson's Disease	31
Determinants of Infarct Core Growth During Inter‐hospital Transfer for Thrombectomy	31
Issue Information	31
Investigation of Autosomal Genetic Sex Differences in Parkinson's Disease	31
Reply to “Chance Bias Arising from TSC2 Mutation Imbalance in the PREVeNT Trial”	30
	30
Issue Information	30
Is there an Association between Tuber Involvement of the Fusiform Face Area in Autism Diagnosis?	30
Trigeminal Trophic Syndrome from Lateral Medullary Stroke	30
Nocturnal Pulse Event Frequency Is Reduced in Multiple System Atrophy	30
	30
Prophylactic Fetal Creatine Supplementation Improves Post‐Asphyxial EEG Recovery and Reduces Seizures in Fetal Sheep: Implications for Hypoxic–Ischemic Encephalopathy	29
Promise of Nucleic Acid Therapeutics for Amyotrophic Lateral Sclerosis	29
Recessive Variants in PIGG Cause a Motor Neuropathy with Variable Conduction Block, Childhood Tremor, and Febrile Seizures: Expanding the Phenotype	29
Reply to “Letter on Multiple Acyl‐Coenzyme A Dehydrogenase Deficiency Is Associated with Sertraline Use”	29
Histopathological Correlates of Lobar Microbleeds in False‐Positive Cerebral Amyloid Angiopathy Cases	28
ANA Podcasts & Webinars: Genetics of Epilepsy	28
Pathogenic MAST3 Variants in the STK Domain Are Associated with Epilepsy	28
Risk of Multiple Sclerosis in People Living with HIV: An International Cohort Study	28
Correction: Decreased Cerebrospinal Fluid Amyloid β 38, 40, 42, and 43 Levels in Sporadic and Hereditary Cerebral Amyloid Angiopathy	28
Reply to “Is There an Association between Tuber Involvement of the Fusiform Face Area in Autism Diagnosis?”	28
In Memoriam: Arthur Knight Asbury, MD (1928–2022)	28
Reply to “VAERS Could Miss or Misinterpret Neurological Side Effects of COVID Vaccinations”	28
Issue Information – TOC	27
Impact of Time of Day and Season on Outcome in Acute Ischemic Stroke	27
Issue Information	27
Issue Information	27
Search Strategies for Alzheimer Protector Genes	27
Subcortical Volumes as Early Predictors of Fatigue in Multiple Sclerosis	26
Encephalitis with Autoantibodies against the Glutamate Kainate Receptors GluK2	26
ANA Investigates: Atrial Fibrillation after Stroke	26
Adolescent Headache Due to Congenital Pelvic/Sacral Vascular Malformation	26
Pivotal Role of Slitrk1 in Adult Striatal Cholinergic Neurons in Mice: Implication in Tourette Syndrome	26
Neuromyelitis Optica Spectrum Disorder: Therapeutic Innovations and Complex Decision‐Making	26
Application of the Amyloid/Tau/Neurodegeneration Framework in Cognitively Intact Adults: The CABLE Study	26
	26
Extra Movements in Healthy People: Challenging the Definition and Diagnostic Practice of Tic Disorders	26
Evaluation of Soluble Colony Stimulating Factor 1 Receptor (CSF1R) in Peripheral Blood as a Diagnostic Marker of CSF1R‐Related Disorder (CSF1R‐RD) in a Muri	26
Disease‐Modifying Drugs Extend Survival in Hereditary Transthyretin Amyloid Polyneuropathy	26
Spoken Language Alterations can Predict Phenoconversion in Isolated Rapid Eye Movement Sleep Behavior Disorder: A Multicenter Study	25
CADASIL Affects Multiple Aspects of Cerebral Small Vessel Function on 7T‐MRI	25
Cerebral Small Vessel Disease Progression Increases Risk of Incident Parkinsonism	25
Emerging Management Challenges Posed by Atrial Fibrillation Detected After Stroke	25
Issue Information	25
Comparative Safety of Antiseizure Medication Monotherapy for Major Malformations	25
α4β2* Nicotinic Cholinergic Receptor Target Engagement in Parkinson Disease Gait–Balance Disorders	25
Ultra‐Low Level Somatic Mutations and Structural Variations in Focal Cortical Dysplasia Type II	25
“Don't Throw the Baby out with the Bathwater”	25
Cinematic Rendering of Extracranial to Intracranial Arterial Bypass	25
SRPK3 Is Essential for Cognitive and Ocular Development in Humans and Zebrafish, Explaining X‐Linked Intellectual Disability	25
Cortical Correlates of Gait Compensation Strategies in Parkinson Disease	25
Smouldering‐Associated Worsening in Multiple Sclerosis: An International Consensus Statement on Definition, Biology, Clinical Implications, and Future Directions	25
Annals of Neurology: Volume 95, Number 4, April 2024	25
Issue Information	24
Internal Carotid Artery Pseudoaneurysm and Unilateral Vocal Cord Paralysis Secondary to Parapharyngeal Space Abscess	24
Temporal Pattern of Cortical Hypoxia in Multiple Sclerosis and Its Significance on Neuropsychological and Clinical Measures of Disability	24
Fixating with the Paretic Eye: Evidence of “Fixation Duress” on PET Imaging	24
Brainstem Ischemic Syndrome in NF2‐Related Schwannomatosis	24
Annals of Neurology: Volume 96, Number 2, August 2024	24
NORSE, FIRES, and a Polygenic Trickle of Autoimmunity	24
Issue Information	24

Issue Information	24
Correction to Lyden P, Pryor KE, Coffey CS, et al. Final results of the RHAPSODY trial: a multi‐center, phase 2 trial using a continual reassessment method to determine the safety and toler	24
Systemic Metabolic Alteration Dependent on the Thyroid‐Liver Axis in Early PD	24
Neutrophils Are Associated with Higher Risk of Incident Amyotrophic Lateral Sclerosis in a BMI‐ and Age‐Dependent Manner	23
Prediction of Cognitive Heterogeneity in Parkinson's Disease: A 4‐Year Longitudinal Study Using Clinical, Neuroimaging, Biological and Electrophysiological Biomarkers	23
Network Localization of Pediatric Lesion‐Induced Dystonia	23
Annual Report from the Editor‐in‐Chief (2024)	23
A Carotid Web with Atherosclerotic Plaque	23
Intravenous Thrombolysis with Tenecteplase for the Treatment of Acute Ischemic Stroke	22
Sex Differences in Trends in Stroke Recurrence and Postrecurrence Mortality 2000–2020: Population‐Based Brain Attack Surveillance in Corpus Christi Project	22
Disease Progression in Charcot–Marie–Tooth Disease Related to MPZ Mutations: A Longitudinal Study	22
Insular Stimulation Produces Mental Clarity and Bliss	22
Diagnosing Epilepsy with Normal Interictal EEG Using Dynamic Network Models	22
High Levels of Perivascular Inflammation and Active Demyelinating Lesions at Time of Death Associated with Rapidly Progressive Multiple Sclerosis Disease Course: A Retrospective Postmortem Cohort Stud	22
Activated Wake Systems in Narcolepsy Type 1	22
De Novo Missense Variants in SLC32A1 Cause a Developmental and Epileptic Encephalopathy Due to Impaired GABAergic Neurotransmission	22
Salivary CGRP and Erenumab Treatment Response: Towards Precision Medicine in Migraine	21
Social Health and Cognitive Change in Old Age: Role of Brain Reserve	21
Limbic Stimulation Drives Mania in STN‐DBS in Parkinson Disease: A Prospective Study	21
Association of Apolipoprotein E ɛ4 Allele with Enlarged Perivascular Spaces	21
	21
Vessel Wall Imaging of a Carotid Web	21
Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple Sclerosis	21
Inflammation in Cerebral Amyloid Angiopathy‐Related Transient Focal Neurological Episodes	21
Non–Cell Autonomous Epileptogenesis in Focal Cortical Dysplasia	20
Issue Information	20
	20
Reply to “Myelin Oligodendrocyte Glycoprotein Antibody‐Positive Patients Meeting the 2017 McDonald Criteria for Multiple Sclerosis: Challenges in Diagnosis and Treatment Decisions”	20
Fostering Academia‐Industry Partnerships to Facilitate Therapeutic Discoveries in Neurology: The Role of ANA as a Catalyst	20
Role of the Exposome in Neurodegenerative Disease: Recent Insights and Future Directions	20
Annals of Neurology: Volume 92, Number 3, September 2022	20
MOG‐IgG‐Associated Bilateral Optic Neuritis in Temporal Relation to Monkeypox Vaccination	20
Enhancement of Glutamate Uptake as Novel Antiseizure Approach: Preclinical Proof of Concept	20
Life‐Limiting Peripheral Organ Dysfunction in Feline Sandhoff Disease Emerges after Effective CNS Gene Therapy	20
Hydroxychloroquine for Primary Progressive Multiple Sclerosis	20
Charcot Joint	20
	20
Proteomic Indicators of Health Predict Alzheimer's Disease Biomarker Levels and Dementia Risk	20
Cognitive Effects of Deep Brain Stimulation in GBA‐Related Parkinson Disease	20
Spasticity Predicts Motor Recovery for Patients with Subacute Motor Complete Spinal Cord Injury	19
Dominant KPNA3 Mutations Cause Infantile‐Onset Hereditary Spastic Paraplegia	19
Re‐Emergence of Poliovirus in the United States: Considerations and Implications	19
Cinematic Rendering of Twig‐Like Middle Cerebral Artery	19
AI in Neurology: Everything, Everywhere, All at Once Part 3: Surveillance, Synthesis, Simulation, and Systems	19
Neuroprotection of Low‐Frequency Repetitive Transcranial Magnetic Stimulation after Ischemic Stroke in Rats	19
Phase 1 Evaluation of Elezanumab (Anti–Repulsive Guidance Molecule A Monoclonal Antibody) in Healthy and Multiple Sclerosis Participants	19
Postictal Psychosis in Epilepsy: A Clinicogenetic Study	19
Networks Underlie Temporal Onset of Dysplasia‐Related Epilepsy: A MELD Study	19
Divergent Causes and Convergent Mechanisms of SUDEP	18
Longitudinal Alterations of Cerebral Blood Flow in High‐Contact Sports	18
MuSK‐Myasthenia Gravis and Cancer	18
Microglial and Astrocytic Responses in the Human Midcingulate Cortex in Huntington's Disease	18
	18
Blood‐Based Proteomics for Adult‐Onset Focal Dystonias	18
Ablating the Transporter Sodium‐Dependent Dicarboxylate Transporter 3 Prevents Leukodystrophy in Canavan Disease Mice	18
Genetically Determined Low‐Density Lipoprotein Cholesterol and Risk of Subarachnoid Hemorrhage	18
Pragmatic Clinical Trials in Neurology	18
Levodopa Impairs the Energy Metabolism of the Basal Ganglia In Vivo	18
Intact HIV Proviruses Persist in the Brain Despite Viral Suppression with ART	18
Presynaptic Dopaminergic Imaging Characterizes Patients with REM Sleep Behavior Disorder Due to Synucleinopathy	18
Myelin Oligodendrocyte Glycoprotein Antibody‐Positive Patients Meeting the 2017 McDonald Criteria for Multiple Sclerosis: Challenges in Diagnosis and Treatment Decisions	18
APOE Antibody Inhibits Aβ‐Associated Tau Seeding and Spreading in a Mouse Model	17
Mutations in HID1 Cause Syndromic Infantile Encephalopathy and Hypopituitarism	17
Annals of Neurology: Volume 93, Number 4, April 2023	17
Reply to “Type I IFN Signature in NOTCH1‐Related Leukoencephalopathy”	17
Perimesencephalic Hemorrhage from A Superior Cerebellar Artery Dissection	17
The Starry Cortex of Aβ‐Related Angiitis	17
Cluster Headache Genomewide Association Study and Meta‐Analysis Identifies Eight Loci and Implicates Smoking as Causal Risk Factor	17
Annals of Neurology: Volume 90, Number 6, December 2021	17
Inhibition of Bone Morphogenetic Protein Signaling Prevents Tau Pathology in iPSC Derived Neurons and PS19 Mice	17
Thalamic Influence on Slow Wave Slope Renormalization During Sleep	17
Annals of Neurology: Volume 95, Number 3, March 2024	16
Longitudinal Retinal Changes in MOGAD	16
Eligibility Rates among Racially and Ethnically Diverse US Participants in Phase 2 and Phase 3 Placebo‐Controlled, Double‐Blind, Randomized Trials of Lecanemab and Elenbecestat in Early Alz	16
Association of Mismatch Profiles and Clinical Outcome from Endovascular Therapy in Large Infarct: A Post‐Hoc Analysis of the ANGEL‐ASPECT Trial	16
Obesity and Multiple Sclerosis Severity: A Mendelian Randomization Study	16
Clinically Meaningful Magnetic Resonance Endpoints Sensitive to Preataxic Spinocerebellar Ataxia Types 1 and 3	16
Cost‐Effectiveness of Endovascular Thrombectomy in Patients with Large Ischemic Stroke	16
Characterizing Frontal Lobe Seizure Semiology in Children	16
Disparate Dementia Risk Factors Are Associated with Cognitive Impairment and Rates of Decline in African Americans	16
Natural History of Leigh Syndrome: A Study of Disease Burden and Progression	16
Divergent Associations of Slow‐Wave Sleep versus Rapid Eye Movement Sleep with Plasma Amyloid‐Beta	16
Early Treatment with Vigabatrin Does Not Decrease Focal Seizures or Improve Cognition in Tuberous Sclerosis Complex: The PREVeNT Trial	16
Characterization of Extracranial Giant Cell Arteritis with Intracranial Involvement and its Rapidly Progressive Subtype	16
Amyloid‐Related Imaging Abnormalities in the DIAN‐TU‐001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease	16
Cerebrospinal Fluid Analysis Post–COVID‐19 Is Not Suggestive of Persistent Central Nervous System Infection	16
Mutations in CLCN6 as a Novel Genetic Cause of Neuronal Ceroid Lipofuscinosis in Patients and a Murine Model	16
	15
	15
	15
Frequency and Early Predictors of Cognitive Deterioration in Amyotrophic Lateral Sclerosis: A Longitudinal Population‐Based Study	15
Annals of Neurology: Volume 96, Number 5, November 2024	15
In Vivo Assessment of Astrocyte Reactivity in Patients with Progressive Supranuclear Palsy	15
Letter on Wine Glass Sign in Bulbar‐Onset Amyotrophic Lateral Sclerosis	15
Effect of Mobile Stroke Unit Dispatch in all Patients with Acute Stroke or TIA	15